Senior insider sale
SVP, Chief Marketing Officer at VANDA PHARMACEUTICALS INC. — senior position signals high conviction
$21.7K
3.72K shares
What this filing means
WIJKSTROM JOAKIM plans to sell 3.72K shares of VANDA PHARMACEUTICALS INC. valued at approximately $21.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/21/2023ACC: 0001802653-23-000002
Officer· SVP, Chief Marketing Officer
Since Aug 2019
3.72K
Shares to sell
$21.7K
Approx. market value
3.72K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Vesting/Settlement of Restricted Stock Units
Compensation
8/19/2023
3.72KTotal acquired3.72K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/19/2023 | Vesting/Settlement of Restricted Stock Units Compensation | 3.72K | — |
| Total | 3.72K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
3.72K
Market value
$21.7K
8/21/2023
Total
Units
3.72K
Value
$21.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/21/2023 | 3.72K | $21.7K | Nasdaq | Planned |
| Total | 3.72K | $21.7K | ||